Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis ; volume:9 ; number:1 ; day:14 ; month:9 ; year:2011 ; pages:1 ; date:12.2011
Pediatric rheumatology ; 9, Heft 1 (14.9.2011), 1, 12.2011
- Urheber
-
Bulatović, Maja
Vastert, Sebastiaan
Verweij, Frederik
Wulffraat, Nico
van Wijk, Femke
Prakken, Berent
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-9-S1-P131
- URN
-
urn:nbn:de:101:1-2021082518545556670385
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bulatović, Maja
- Vastert, Sebastiaan
- Verweij, Frederik
- Wulffraat, Nico
- van Wijk, Femke
- Prakken, Berent
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictors of response to methotrexate in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Methotrexate
Responsiveness to exercise training in juvenile dermatomyositis: a twin case study
Predictors of response to methotrexate in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Methotrexate
Responsiveness to exercise training in juvenile dermatomyositis: a twin case study
Predictors of response to methotrexate in juvenile idiopathic arthritis
Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis
Efficacy of oral versus subcutaneous methotrexate in children with juvenile idiopathic arthritis
Oral or Parenteral Methotrexate for treatment of Non- Systemic Juvenile Idiopathic Arthritis
Methotrexate